Cn / En

CM05257


CM05257

Key word结直肠癌, PDX, 体内药效,体外药效,免疫系统人源化,5-FU, SN38, 奥沙利铂, 吉西他滨, 曲美替尼, 顺铂, 依维莫司, 长春新碱, 紫杉醇,

Model Information

Model IDCM05257
Cancer Type结直肠癌(肝转移)
Cell Subtype腺癌
Differentiation中分化
Collection Site肝
Metastatic Site肝转移
GradeII
TNM stagingM1a
IHC diagnosisEGFR(3+), HER2(0), KI67(50~75%+), MLH1(+), MSH2(+), MSH6(+), PMS2(+)
Pathology diagnosis诊断:肝转移术后复发射频后。直肠癌术后 5(原发灶部位1-右半结肠,2-横结肠,3-左半结肠,4-乙状结肠,5-直肠)免疫组化结果显示转移癌: EGFR(3+),HER2 (0),KI67 (+50~ 75%),MLH1 (+), MSH2 (+),MSH6(+), PMS2(+)。
Clinical Treatment Records 

Model Data

Histopathological Images

 

Tumor growth curve

  

In vivo efficacy of SOCs

  
  
  
  

In vitro efficacy of SOCs